If you liked this article you might like

Analysts' Actions -- Apple, Aetna, DineEquity, Silgan and More
Why It's Unhealthy to Own Rite Aid, Plus Jim Cramer's Take
Trading Battered Qualcomm and Rite Aid? Here's What to Do Now
Rite Aid Takes a Beating After Report of Walgreens Deal Fears